Neurotherapeutics is a quarterly peer-reviewed medical journal covering research on experimental treatments of neurological disorders.

It was established in 2004 and is published by Springer Science+Business Media on behalf of the American Society for Experimental NeuroTherapeutics.

The editor-in-chief is Maral Mouradian (Robert Wood Johnson Medical School).

The founding editor-in-chief was Alan I. Faden (University of Maryland School of Medicine).

The journal is abstracted and indexed in: According to the Journal Citation Reports, the journal has a 2020 impact factor of 7.620.